Spectrophotometric determination of risedronate in pharmaceutical formulations via complex formation with Cu (II) ions: Application to content uniformity testing

International Journal of Biomedical Science

Volumn 4, Issue 4, 2008, Pages 303-309

  Walash, M I ^a   Metwally, M E S ^a   Eid, M ^a   El Shaheny, Rania N ^a  

^a MANSOURA UNIVERSITY   (Egypt)

Author keywords

Complex formation; Content uniformity; Copper (II) sulfate; Risedronate; Spectrophotometry

Indexed keywords

ACETIC ACID; BUFFER; COPPER ION; RISEDRONIC ACID;

ARTICLE; COMPLEX FORMATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG DETERMINATION; DRUG FORMULATION; DRUG STRUCTURE; PH; SPECTROPHOTOMETRY; TABLET;

EID: 70350572073     PISSN: 15509702     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Sweetman S., Martindale, The Complete Drug Reference. The Pharmaceutical Press: London, 2007; Electronic version.
2. Goodman L.S., Gilman A., The pharmacological Basis of Therapeutics, 10th ed., McGraw Hill, Medical Publication Division, New York, 2001; 1733.
3. Taha E.A., Youssef N.F. Spectrophotometric Determination of Some Drugs for Osteoporosis. Chem. Pharm. Bull. 2003; 51(12):1444.
4. Zhu L.S., Lapko V.N., Lee J.W., Basir Y.T., et al. A general Approach for the Quantitative Analysis of Bisphosphonates in Human Serum and Urine by High-Performance Liquid Chromatography/Tandem Mass Spectrometry. Rapid. Commun. Mass. Spectrom. 2006; 20(22):3421.
5. Mitchell D.Y., Eusebio R.A., Sacco-Gibson N.A., Pallone K.A., et al. Dose-Proportional Pharmacokinetics of Risedronate on Single-Dose Administration to Healthy Volunteers. J. Clin. Pharmacol. 2000; 40(3):258.
6. Jia H.J., Li W., Zhao K. Determination of Risedronate in Rat Plasma By Ion-Pair High-Performance Liquid Chromatography With UV Detector. Anal. Chem. Acta. 2006; 562(2):171.
7. Auoch A., Tatini R., Parsons D.M., Sadik O. Stability Indicating Ion-Pair HPLC Method for The Determination of Risedronate in A commercial Formulation. J. Liq. Chromatogr. Rel. Technol. 2004; 27 (17):2799.
8. Kyriakides D., Panderi I. Development and Validation of A reversed-Phase Ion-Pair High Performance Liquid Chromatographic method for the Determination of Risedronate in Pharmaceutical Preparations. Anal. Chem. Acta. 2007; 584(1):153.
9. Vallano P.T., Shugats S.B., Kline W.F., Woolf E.J., Matusezewski B.K. Determination of Risedronate in Human Urine by Column-Switching Ion-Pair High-Performance Liquid Chromatography With Ultraviolet Detection. J. Chromatogr. B. 2003; 794 (1):23.
10. Kuljanin J., Janković I., Nedeljković J., Prstojević D., Marinković V. Spectrophotometric determination of Alendronate in Pharmaceutical formulations via complex formation with Fe(III) Ions. J. Pharm. Biomed. Anal. 2002; 28:1215.
11. Ostovic D., Stelmach C., Hulshizer B. Formation of A chromophoric Complex Between Alendronate and Copper(II) Ions. Pharm Res. 1993; 10(3):470.
12. Tsai E.W., Singh M.M., Lu H.H., Ip D.P., Brooks, M.A. Application of Capillary Electrophoresis to Pharmaceutical Analysis. Determination of Alendronate in Dosage Forms. J. Chromatogr. 1992; 626(2):245.
13. Tzanavaras P.D., Zacharis C.K., Theodoridis G.A., Kalaitzantonakis E.A., Voulgaropoulos A.N. Normal Spectrophotometric and Stopped-Flow Spectrofluorimetric Sequential Injection Methods for the Determination of Alendronic Acid, an Anti-osteoporosis Amino-biphosphonate Drug, in Pharmaceuticals. Anal. Chem. Acta 2005; 547 (1):98.
14. Shallan A.I.G., Master Thesis, Faculty of Pharmacy, University of Helwan: Cairo, Egypt; 2007.
15. Miller J.C., Miller J.N., Statistics and Chemometrics for Analytical Chemistry, 5th ed., Pearson Education Limited: Harlow, England; 2005.
16. Inczédy J., Analytical Application of Complex Equilibria, John Wiley & Sons Inc., Budapest; 1976.
17. ICH Harmonized Tripartite Guideline, Validation of Analytical Procedures: Text and Methodology, Q2 (R1), Current Step 4 Version, Parent Guidelines on Methodology Dated November 6, 1996, Incorporated in November 2005. http://www.ich.org/LOB/media/MEDIA417.pdf (accessed February 15, 2008)
18. The United States Pharmacopoeia 30th and The National formulary 25th; 2007, Rockville, MD, USA; Electronic Version.